Holen Sie sich die Stockscreener-App
19.95
0.71%
0.14
Handel nachbörslich:
19.95
Fulgent Genetics Inc Aktie (FLGT) Neueste Nachrichten
Renaissance Technologies LLC Decreases Stock Position in Fulgent Genetics, Inc. $FLGT - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Share Price Crosses Below Fifty Day Moving AverageHere's What Happened - MarketBeat
Fulgent Genetics details new protocols for variant reclassification and segregation testing recommendations - tradersunion.com
Fulgent Genetics (FLGT) Q2 2026 Earnings Call Transcript - AOL.com
Fulgent Genetics, Inc. $FLGT Shares Purchased by Quantinno Capital Management LP - MarketBeat
FLGT Q2 2026 Earnings: EPS Misses Estimates as Costs Weigh on ResultsEarnings Preview - vinanet.vn
Discipline and Rules-Based Execution in FLGT Response - Stock Traders Daily
Fulgent Genetics, Inc. $FLGT Shares Sold by Dimensional Fund Advisors LP - MarketBeat
Wall Street Zen Downgrades Fulgent Genetics (NASDAQ:FLGT) to Strong Sell - MarketBeat
Fulgent Genetics, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:FLGT) 2026-08-07 - Seeking Alpha
Price to sales forward of Fulgent Genetics, Inc. – MUN:7F0 - TradingView
Fulgent Genetics, Inc. (FLGT) Stock Analysis: Navigating a Complicated Financial Landscape in Healthcare - DirectorsTalk Interviews
FLGT Q1 2026 Earnings: Wider-than-Expected Loss Despite Positive Stock MovementEarnings Miss Alert - vinanet.vn
Fulgent Genetics (FLGT) Stock Gets Fair Value Boost After Analysts Raised Targets - Yahoo Finance
Fulgent Deadline Alert - TMX Newsfile
FLGT Maintained by Piper Sandler -- Price Target Raised to $19.0 - GuruFocus
Piper Sandler Maintains Fulgent Genetics(FLGT.US) With Hold Rating, Cuts Target Price to $19 - Moomoo
Fulgent Genetics Inc (7F0) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
FLGT Q1 2026 Earnings: EPS Misses Estimates by 23.6%, Shares Tumble 18%Pre-Announcement Alert - vinanet.vn
FLGT Q1 2026 Earnings: EPS Misses Estimates by 23.6% as Shares Slide 18%Revenue Miss Report - vinanet.vn
Fulgent Genetics (NASDAQ:FLGT) Announces Quarterly Earnings Results - MarketBeat
Fulgent Genetics Inc (FLGT) (Q2 2026) Earnings Call Highlights: Strategic Progress Amid Revenue ... By GuruFocus - Investing.com Canada
Earnings call transcript: Fulgent Genetics cuts 2026 outlook after q2 miss - Investing.com Nigeria
FLGT Looks 16.7% Undervalued on GF Value™ Despite Revenue Miss - GuruFocus
Fulgent Genetics (FLGT) Releases Q2 2026 Earnings: Revenue Growth but EPS Miss - Quiver Quantitative
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022. - marketscreener.com
Fulgent Genetics, Inc. Revises Earnings Guidance for the Year Ending December 31, 2026 - marketscreener.com
Fulgent Genetics cuts FY26 revenue guidance amid billing delays - scanx.trade
Behavioral Patterns of FLGT and Institutional Flows - Stock Traders Daily
Fulgent Genetics CFO Kim Paul Executes Tax-Driven Share Withholding, Sells 2,747 Shares at $19.67 Each - Kalkine Media
Fulgent Genetics Inc (FLGT) Cash Flow - TradingKey
Fulgent Genetics Inc (FLGT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Fulgent Genetics Inc (FLGT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Fulgent Genetics Inc (FLGT) Institutional Confidence - TradingKey
FLGT|Fulgent Genetics Inc|Price:19.670|Chg%:-0.310 - TradingKey
Fulgent Genetics Slips 1.5% as Shares Test Key Support LevelsALMA Signal - dars.gov.et
TradingKey - TradingKey
FLGT|Fulgent Genetics Inc|Price:19.557|Chg%:-0.113 - TradingKey
Fulgent Genetics, Inc. Revenue Breakdown – FWB:7F0 - TradingView
FULGENT GENETICS, INC. (FLGT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT) - TMX Newsfile
Fulgent Genetics (FLGT.US) will release its earnings report after market close on July 30. - 富途牛牛
Fulgent Genetics, Inc. (FLGT) Stock Analysis: Navigating Challenges with a -7.41% Potential Downside - DirectorsTalk Interviews
Fulgent Genetics Inc (FLGT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Fulgent Genetics (FLGT) to Release Earnings on Thursday - MarketBeat
(FLGT) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Fulgent Genetics (FLGT) Dips 1.9% as Stock Tests Support Zone Near $19.15Momentum Trade - Vinanet
ETFs Investing in Fulgent Genetics, Inc. Stocks - TradingView
Fulgent Genetics seen as undervalued with stron... - Pluang
Fulgent Genetics: Strong Moves By Management Keep Me Bullish (NASDAQ:FLGT) - Seeking Alpha
Y Intercept Hong Kong Ltd Invests $1.08 Million in Fulgent Genetics, Inc. $FLGT - MarketBeat
Fulgent Genetics Inc. (FLGT) Q1 2026 Earnings: EPS Misses Estimates as Losses Widen, Shares Edge Lower - dars.gov.et
Fulgent to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026 - Business Wire
Fulgent Genetics to announce Q2 2026 results on July 30 - scanx.trade
Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual Meeting - AOL.com
FLGTFulgent Genetics Inc Forecast, Target Price - Finviz
Enterprise value to EBITDA forward of Fulgent Genetics, Inc. – NASDAQ:FLGT - TradingView
Fulgent Genetics (FLGT) Dips 1%: Testing Key Support Near $19.3 Amid Mixed Technical SignalsVOLD Alert - dars.gov.et
Price to earnings forward of Fulgent Genetics, Inc. – NASDAQ:FLGT - TradingView
Enterprise value to EBIT forward of Fulgent Genetics, Inc. – NASDAQ:FLGT - TradingView
Enterprise value to EBIT forward of Fulgent Genetics, Inc. – BMV:FLGT - TradingView
Enterprise value to revenue forward of Fulgent Genetics, Inc. – NASDAQ:FLGT - TradingView
Price to earnings forward of Fulgent Genetics, Inc. – BMV:FLGT - TradingView
Price to book forward of Fulgent Genetics, Inc. – NASDAQ:FLGT - TradingView
Price to sales forward of Fulgent Genetics, Inc. – BMV:FLGT - TradingView
0.24%
1.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):